Previous 10 | Next 10 |
Summary The Health Care sector and Biotech niche have both been interesting sources of relative market strength in recent months; one defensive, one more risk-on. 10x Genomics was a massive winner around the Covid-19 pandemic, but an improving health situation around the world pos...
Summary The average stock in the Russell 3,000 was down 41.7% from its 52-week high as of the close on Monday. Four sectors have average prices roughly 50% below their 52-week highs - Communication Services at -51.8%, Consumer Discretionary at -49.8%, Tech at -49.4%, and Health Ca...
Summary Generation Investment Management’s 13F portfolio value decreased from $21.84B to $18.35B this quarter. They added Mastercard and increased Amazon.com, Microsoft, Trane Technologies, and Analog Devices while reducing Baxter International, Becton Dickinson, and Alphab...
10x Genomics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference PR Newswire PLEASANTON, Calif. , Sept. 2, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human he...
10x Genomics, Inc. ( NASDAQ: TXG ) dropped ~6% in the pre-market trading Thursday after Gladman Sachs downgraded the life sciences company to Sell from Neutral, citing a significantly slower trajectory for its future sales growth. The price target set to $35 per share impl...
Recent volatility mirror renewed meme-trade bonanza, likely to subdue in coming days, instead of a reflection of a change in the company's market position. Several factors distorted the YoY revenue comparison this quarter, contributing to the inflated top-line growth, including the Bi...
Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Fifth Avenue Growth Fund (the “Fund”) lost 30.6% (Institutional Shares) during the second quarter. ...
Baillie Gifford’s 13F portfolio value decreased from ~$143B to ~$97.51B this quarter. They increased Spotify and Royalty Pharma while decreasing Cloudflare, Petrobras, BeiGene, CBRE Group, Teladoc, and Peloton Interactive. The top three positions are Moderna, Tesla Motors, ...
10x Genomics, Inc. (TXG) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Cassie Corneau - Investor Relations and Strategic Finance Serge Saxonov - Chief Executive Officer & Co-founder Jim Wilbur - Chief Commercial Officer J...
10x Genomics press release ( NASDAQ: TXG ): Q2 GAAP EPS of -$0.57. Revenue of $114.61M (-1.1% Y/Y). Shares -2% . Outlook: 10x Genomics is updating its outlook for the full year 2022. The company now expects revenue to be in the range of $500 million to $520 mil...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:09 ET Kyle Mikson from Canaccord Genuity issued a price target of $32.00 for TXG on 2024-07-23 05:09:00. The adjusted price target was set to $32.00. At the time of the announcement, TXG was trading at $18.11. The overall price target consensus is at $24...
10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLEASANTON, Calif. , July 12, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report fi...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...